366 related articles for article (PubMed ID: 19699189)
21. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
22. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area.
Fadel J; Deutch AY
Neuroscience; 2002; 111(2):379-87. PubMed ID: 11983323
[TBL] [Abstract][Full Text] [Related]
23. Ghrelin acts as an interface between physiological state and phasic dopamine signaling.
Cone JJ; McCutcheon JE; Roitman MF
J Neurosci; 2014 Apr; 34(14):4905-13. PubMed ID: 24695709
[TBL] [Abstract][Full Text] [Related]
24. Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats.
Morgan AJ; Harrod SB; Lacy RT; Stanley EM; Fadel JR
Drug Alcohol Depend; 2013 Oct; 132(3):562-70. PubMed ID: 23664126
[TBL] [Abstract][Full Text] [Related]
25. Neural correlates and potential targets for the contribution of orexin to addiction in cortical and subcortical areas.
Kourosh-Arami M; Gholami M; Alavi-Kakhki SS; Komaki A
Neuropeptides; 2022 Oct; 95():102259. PubMed ID: 35714437
[TBL] [Abstract][Full Text] [Related]
26. Lateral hypothalamic neuropeptides in reward and drug addiction.
DiLeone RJ; Georgescu D; Nestler EJ
Life Sci; 2003 Jun; 73(6):759-68. PubMed ID: 12801597
[TBL] [Abstract][Full Text] [Related]
27. A role for lateral hypothalamic orexin neurons in reward seeking.
Harris GC; Wimmer M; Aston-Jones G
Nature; 2005 Sep; 437(7058):556-9. PubMed ID: 16100511
[TBL] [Abstract][Full Text] [Related]
28. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.
Muschamp JW; Hollander JA; Thompson JL; Voren G; Hassinger LC; Onvani S; Kamenecka TM; Borgland SL; Kenny PJ; Carlezon WA
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1648-55. PubMed ID: 24706819
[TBL] [Abstract][Full Text] [Related]
29. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
Arias-Carrión O; Bradbury M
CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
[TBL] [Abstract][Full Text] [Related]
30. Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory.
Eacret D; Grafe LA; Dobkin J; Gotter AL; Renger JJ; Winrow CJ; Bhatnagar S
Behav Brain Res; 2019 Jan; 356():444-452. PubMed ID: 29902478
[TBL] [Abstract][Full Text] [Related]
31. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement.
Sharf R; Sarhan M; Brayton CE; Guarnieri DJ; Taylor JR; DiLeone RJ
Biol Psychiatry; 2010 Apr; 67(8):753-60. PubMed ID: 20189166
[TBL] [Abstract][Full Text] [Related]
32. [Orexin: clinical and therapeutic implications].
Mediavilla C; Risco S
Rev Neurol; 2014 Feb; 58(3):117-24. PubMed ID: 24469938
[TBL] [Abstract][Full Text] [Related]
33. Functional interaction between OX2 and CB1 receptors in the ventral tegmental area and the nucleus accumbens in response to place preference induced by chemical stimulation of the lateral hypothalamus.
Yazdi F; Jahangirvand M; Pirasteh AH; Moradi M; Haghparast A
Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):39-46. PubMed ID: 26494513
[TBL] [Abstract][Full Text] [Related]
34. Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity.
Baimel C; Borgland SL
J Neurosci; 2015 May; 35(18):7295-303. PubMed ID: 25948277
[TBL] [Abstract][Full Text] [Related]
35. The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System.
Fragale JE; James MH; Avila JA; Spaeth AM; Aurora RN; Langleben D; Aston-Jones G
Front Neurol Neurosci; 2021; 45():117-127. PubMed ID: 34052815
[TBL] [Abstract][Full Text] [Related]
36. The hypocretins and their role in narcolepsy.
Kroeger D; de Lecea L
CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):271-80. PubMed ID: 19689309
[TBL] [Abstract][Full Text] [Related]
37. A Review of the Physiological Role of Hypocretin in the Ventral Tegmental Area in Reward and Drug Dependence.
Kourosh-Arami M; Komaki A; Gholami M
Protein Pept Lett; 2023; 30(8):619-625. PubMed ID: 37409547
[TBL] [Abstract][Full Text] [Related]
38. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.
Cason AM; Smith RJ; Tahsili-Fahadan P; Moorman DE; Sartor GC; Aston-Jones G
Physiol Behav; 2010 Jul; 100(5):419-28. PubMed ID: 20338186
[TBL] [Abstract][Full Text] [Related]
39. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.
Narita M; Nagumo Y; Hashimoto S; Narita M; Khotib J; Miyatake M; Sakurai T; Yanagisawa M; Nakamachi T; Shioda S; Suzuki T
J Neurosci; 2006 Jan; 26(2):398-405. PubMed ID: 16407535
[TBL] [Abstract][Full Text] [Related]
40. The potential role of the orexin reward system in future treatments for opioid drug abuse.
Zarrabian S; Riahi E; Karimi S; Razavi Y; Haghparast A
Brain Res; 2020 Mar; 1731():146028. PubMed ID: 30476469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
